ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
PROSPECTS FOR CLINICALLY TOLERATED NMDA ANTAGONISTS - OPEN-CHANNEL BLOCKERS AND ALTERNATIVE REDOX STATES OF NITRIC-OXIDE
Author(s): LIPTON SA
Source: TRENDS IN NEUROSCIENCES    Volume: 16    Issue: 12    Pages: 527-532    Published: DEC 1993  
Times Cited: 209     References: 69     
Abstract: Several acute and chronic neurological diseases might be mediated, at least in part, via stimulation of excitatory amino acid receptors, such as the N-methyl-D-aspartate (NMDA) receptor. Antagonists of excitatory amino acid receptors ameliorate neurotoxic damage in several animal models of these disorders. This review focuses on the potential for clinically tolerated NMDA receptor antagonists, with emphasis on agents that have been in clinical use for other conditions and that recently have been shown to inhibit NMDA receptor activity by a mechanism of open-channel block or redox modification.
Document Type: Article
Language: English
Reprint Address: LIPTON, SA (reprint author), CHILDRENS HOSP MED CTR, DEPT NEUROL, CELLULAR & MOLEC LAB, BOSTON, MA 02115 USA
Addresses:
1. BETH ISRAEL HOSP, DEPT NEUROL, BOSTON, MA 02215 USA
2. BRIGHAM & WOMENS HOSP, DEPT NEUROL, BOSTON, MA 02115 USA
3. HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, DEPT NEUROL, BOSTON, MA 02114 USA
Publisher: ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
Subject Category: Neurosciences
IDS Number: MK097
ISSN: 0166-2236
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo